Filing Flows › Health In Tech (HIT) › Guidance & outlook
Health In Tech (HIT) guidance and outlook
Health In Tech (HIT) lowered its guidance on Sep 30, 2026: Revenue $33.0M for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $33.0M | lowered |
From the earnings release filed Sep 30, 2026 (8-K on EDGAR).
Health In Tech's latest quarter
Health In Tech, Q2 2026: revenue $8.1M (-14% year over year), operating margin -41.2%, net loss $2.5M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.
Questions
Did Health In Tech raise or lower its guidance?
Health In Tech (HIT) lowered its guidance on Sep 30, 2026: Revenue $33.0M for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.